Help and information about BioMet Hip Replacement recalls.

Study suggests metal-on-metal hip replacements lack clinical research

February 14th, 2014

A new study published in the BMJ has found that at least 24% of metal-on-metal hip replacements have not been researched to adequately prove clinical effectiveness. The study also shows that 8% of those implanted in 2011 had no clinical study proving effectiveness.

BioMet is one of the several manufacturers who have come under fire for their metal-on-metal hip implants. The BioMet M2a Magnum hip replacement has been found to cause severe complications among hip implant patients.

A 2011 study in the Australian National Joint Registry found that 7.2% of M2a Magnum hip replacements fail and require revision surgery within a year, a rate much higher than normal. Metal hip implant side effects include tissue damage, loosening of the hip, limited mobility and toxic levels of metal in the bloodstream.


Contact Us Today for a Free Consultation.

I am currently represented by an attorney.
*Required fields